
Most cancer patients, such as multiple myeloma, will relapse after treatment. This harsh reality has led scientists to seek new cancer cell targeting mechanisms to improve the depth and tolerance of multiple myeloma treatments...
2020-09-30
Tumors create an unfavorable environment for immune cells (such as T cells) that fight cancer...
2020-09-30
According to the latest data released by researchers at the Abramson Cancer Center of the University of Pennsylvania, CAR-T cells that have undergone Crispr-Cas9 gene editing can persist in cancer patients for several months, and can stably prolifera...
2020-09-30
In a new study, researchers from the University of Pennsylvania and Stanford University combined two state-of-the-art methods-CRISPR (DNA editing) and T cell therapy (using immune system sentinels to destroy tumors)...
2020-09-30
X-chain chronic granulomatous disease (X-chain chronic granulomatous disease, X-CGD) is a rare inherited blood disease...
2020-09-30
Clarifying death receptor signaling is essential for CAR-T cell therapy\\nScientists have found ways to enhance CAR-T cell therapy...
2020-09-30
Demystifying the key role of stem cells in lethal gastric cancer...
2020-09-30
Genetically modified T cells (CAR-T) expressing chimeric antigen receptor (CAR) have been clinically successful in adoptive T cell therapy in B cell malignancies...
2020-09-30
The clinical application of transgenic T cells (CAR-T cells) expressing chimeric antigen receptors (CAR) in the treatment of B-cell malignancies has been successful, but cytokine release syndrome (CRS) prevents this situation...
2020-09-30
Neural progenitor cells (NPC) are a potential treatment for repairing and regenerating neurons after spinal cord injury. However, after NPC is transplanted into rodents, the harmful microenvironment of the damaged spinal cord leads to limited recover...
2020-09-30
Researchers from the National Eye Institute (NEI) are conducting clinical trials to evaluate the clinical safety of the new treatment based on patients’ autologous stem cells for the treatment of geographic atrophy...
2020-09-30
Diabetes is gradually becoming one of the biggest health challenges of our time. According to statistics from the World Health Organization (WHO), one in ten people suffers from diabetes. According to the latest public data, the disease caused 1.6 mi...
2020-09-30
Alzheimer\'s disease (Alzheimer\'s disease, AD) is a progressive neurodegenerative disease, the typical clinical symptoms are cognitive dysfunction, even loss...
2020-09-30
A one-year follow-up led by the University of Texas MD Anderson Cancer Center found that most patients with mantle cell lymphoma (mantle cell lymphoma) who are resistant to previous treatments can benefit from chimerism that targets CD19 antigen...
2020-09-30
In the latest research report published in the international journal “Immunity”, scientists at Emory University have studied the “depleted” immune cells caused by chronic viral infections to provide information on how to improve cancer immunotherapy ...
2020-09-30
A few days ago, in the United States, researchers used gene editing tools to treat three patients with advanced cancer for the first time. At the same time, the results of the phase 1 clinical trial showed high expectations...
2020-09-30